#207 St. John’s Wort for Depression: Flower Power?
CLINICAL QUESTION
Is St. John’s Wort (SJW) an option for treating mild-moderate depression?
BOTTOM LINE
In mild-moderate depression, SJW may improve depression scores and have response or remission rates similar to antidepressants, with fewer reported adverse effects. The evidence is potentially limited by studies of short duration, funding by SJW manufacturers, and inadequately described methods. SJW may be an option for patients experiencing mild to moderate depression who do not want to use standard therapies.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Focusing on seven systematic reviews of randomized controlled trials (RCTs) from the last 10 years, which examined predominantly female patients with moderate depression.1-7
- Compared to placebo:1
- Response rate (defined usually as ≥50% decrease in symptoms), 18 RCTs, 2,922 patients, median follow-up 6 weeks:
- 56% versus 35% placebo (difference statistically significant), Number Needed to Treat (NNT)=5.
- Remission rate (usually defined as minimal depression score), nine RCTs, 1,419 patients:
- No difference.
- Depression scale change:
- Three points on 30-point scale: Statistically significant and clinically detectable difference.
- Adverse effects: No difference.
- Response rate (defined usually as ≥50% decrease in symptoms), 18 RCTs, 2,922 patients, median follow-up 6 weeks:
- Compared to antidepressants (up to 27 RCTs, 3,808 patients):
- Depression scores, response and remission rates: Similar based on fair to poor quality evidence.1-3
- Adverse effects: Fewer.1-3
- Stopping due to adverse effects: 7% anti-depressants versus 4% SJW, NNT=34.2
- Other systematic reviews found similar.4-7
- Effects on suicidal thoughts and behaviours unknown.2
- Limitations:
- Low placebo response rates compared to other antidepressant trials.5
- Studies often sponsored by SJW manufacturers.1
- Short trial durations, different definitions of remission/response, blinding of assessors often not described.1-7
- Many SJW products do not contain what their label claims.8
- Specific adverse effects are poorly described and may include headache,9 photosensitization, skin reactions, and allergies.10
- SJW interacts with many common medications, including:
- Decreased efficacy of oral contraceptives, simvastatin, nifedipine, and warfarin.
- Serotonin syndrome risk if combine SJW with selective serotonin reuptake inhibitors.10
- Antidepressants do not provide much benefit over placebo in mild depression, but are much more effective than placebo in severe depression.11
- There is no reliable evidence for use of SJW in postpartum depression.
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
